Desvenlafaxine 50mg Extended Release Tablet in PCD pharma franchise in Hyderabad

Desvenlafaxine 50mg Extended Release Tablet in pharmaceutical manufacturing company in Mumbai

Desvenlafaxine 50mg Extended Release Tablet in antidepressant pharma franchise in Pune

Desvenlafaxine 50mg Extended Release Tablet in pharma suppliers in Delhi

Desvenlafaxine 50mg Extended Release Tablet in pharma export companies in Kolkata
Denexine OD 50 Tablet in mental wellness pharma franchise opportunities in Bengaluru

Home/Products /devenlafaxine-50mg-extended-release-tablets

About the Product

Description


Denexine OD 50 Tablet contains Desvenlafaxine 50mg in an extended-release formulation. Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that enhances the levels of these neurotransmitters in the brain, helping to stabilize mood and alleviate symptoms of depression. The extended-release nature ensures a steady release of the medicine throughout the day, providing consistent therapeutic benefits and improving patient compliance. It is commonly prescribed in the management of mood disorders and emotional imbalance.


Common side effects may include nausea, dry mouth, dizziness, decreased appetite, constipation, and sweating. Some patients may experience increased blood pressure, insomnia, or sexual dysfunction. Most side effects are mild and temporary, but medical attention should be sought if they persist or worsen.

Denexine OD 50 is primarily indicated for the treatment of major depressive disorder (MDD) in adults. It helps reduce symptoms such as persistent sadness, anxiety, irritability, fatigue, changes in sleep and appetite, and lack of interest in daily activities. It may also be used in other related psychiatric conditions based on a physician’s assessment.

Use Denexine OD 50 only as prescribed by a healthcare professional. Do not stop the medication abruptly, as it may lead to withdrawal symptoms. Caution is advised in patients with hypertension, liver or kidney disease, and those taking other psychiatric medications. Avoid alcohol consumption during therapy.

Store in a cool, dry place between 2°C to 8°C. Protect from light. Reconstitute with sterile water for injection as directed and use immediately after preparation. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Denexine OD 50 Tablet (Desvenlafaxine 50mg Extended Release) in the PCD pharma franchise market?

Denexine OD 50 Tablet has strong demand in the psychiatry and CNS segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on mental healthcare and neuropsychiatric portfolios.

Why should medical distributors include Denexine OD 50 Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for management of depression, anxiety disorders, stress-related conditions, mood disorders, and emotional imbalance. Desvenlafaxine 50mg Extended Release is an SNRI antidepressant that helps improve mood, emotional stability, and mental well-being The extended-release formulation provides sustained therapeutic effect and improved patient compliance This strengthens a reliable psychiatry and CNS-care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Denexine OD 50 Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Denexine OD 50 Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Denexine OD 50 Tablet?

Wholesalers and medical agencies benefit from strong psychiatrist and physician prescriptions, growing demand for mental-health therapies, chronic long-term therapy usage, reliable supply chain support, and good margins in CNS medicines.

How can I become a distributor or franchise partner for Denexine OD 50 Tablet?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.